ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenSwiss Bioscience GmbH
Swiss Bioscience GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Swiss Bioscience GmbH is the development and production of pharmaceutical-grade stem cells, particularly human adipose tissue-derived stem cells (hADSCs), under cGMP conditions. The company offers services such as stem cell banking, research and development, and focuses on the application of stem cells in regenerative medicine, particularly for the treatment of age-related diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Swiss Bioscience GmbH

✓ Offered
8
Stem Cell Banking
Secure, GMP-compliant storage of autologous stem cells for 5 to 25 years, including isolation, processing, cryopreservation and later availability for therapeutic applications.
SVF Banking
Cryopreservation of the stromal vascular fraction from adipose tissue under cGMP conditions, with storage for later regenerative treatments and research applications.
GMP-grade MSCs for research
Ordering and provision of GMP-grade mesenchymal stem cells for research purposes, including sourcing, cultivation and quality testing.
GMP-grade MSCs for clinical applications
Ordering and provision of GMP-grade mesenchymal stem cells for clinical applications, produced using cGMP-compliant processes and quality controls.
Stem cells for regenerative medicine
Stem cell-based applications for regenerative medicine focusing on cell replacement, tissue regeneration and the use of adipose tissue-derived stem cells (hADSCs).
Clinical Collaboration
Collaboration with clinics and laboratories in stem cell research, GMP production and storage within hADSC- and SVF-based projects.
Extracellular Vesicles
Research and development on extracellular vesicles from stem cells, with potential for diagnostic and therapeutic applications.
Exosomes
Research and development on exosomes as preservable, cargo-carrying vesicles for drug delivery and tissue repair.
Trust & reputation

ranQ Trust Score of Swiss Bioscience GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Swiss Bioscience GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Swiss Bioscience GmbH scores 83.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Swiss Bioscience GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Swiss Bioscience GmbH scores 11.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.11.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Swiss Bioscience GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Swiss Bioscience GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Swiss Bioscience GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Swiss Bioscience GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Swiss Bioscience GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 27a
8952 Schlieren

At a glance

Legal form
Limited Liability Company
UID
CHE-495.736.917
Founded
2014 · 12 years
Last commercial register change
March 18, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LB
    LimmaTech Biologics AG
    Schlieren
    SD
    SIEGFRIED DiNAMIQS AG
    Schlieren
    CA
    Cellerys AG
    Schlieren
    FH
    Future Health Pharma GmbH
    Wetzikon Zh 1
    GA
    GlycoEra AG
    Wädenswil
    UA
    UNOMR AG
    Zurich
    SP
    Swiss Plasmabiotech GmbH
    Schwerzenbach
    EA
    Evax AG
    Zurich